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Intcrlcukin (IL)-6 gcnc induction was sludicd in the murinc ccl1 line, L929r?. which is r&tam to the cytotoxic action of tumor necrosis r;lctor 
(TNF). Increasing coixcmrntions ol’ TNF sligh0y clcvxtcd ~hc background lcvcls of IL6 exptcssion as compared IO non4nduccd cells. Under 
conditions where IIIC resistant cells are senshivc IO TNF by combined TNFIIFN-y trcntmcnt. the iL6 IWCIS were strongly induced. This induction 
could be I’urlhcr enhanced by the addilion oflithiumchloridc, or rcduccd by inhibitorsofcytotoxicity, such as dcxamcthasonc. These resultsconfirm 
our carlicr conclusiolis regarding the close rcluiionship betwocn TNF-mcdiutcd IL6 gcnc expression and the pathway leading to cytotoxicity. 
Tumor necrosis Ihcior; Cytotoxichy: Imcrlcukin.6 induction 
1. INTRODUCTION 
Tumor necrosis factor (TNF) is a multifunctional cy- 
tokine which mediates a variety of biological effects 
both in vivo and in vitro [I]. One of the most striking 
effects is its cytostatic/cytotoxic effect on several trans- 
fowled cell lines in vitro, while leaving most normal 
cells unaffected [2.3]. This cellular toxicity is a ‘nucleus- 
independent’ event, the result of several (not yet fully 
understood) cytoplasmic steps. On the other hand TNF 
also induces nuclear events. Several genes are either 
stimulated or repressed after TNF treatment [4]. One of 
the genes induced by TNF in many cell types is the gene 
coding for the secretory protein interleukin (IL)-6 [5,6]. 
Previously, we studied IL6 gene expression in re- 
sponse to TNF in the murine fibrosarcoma cell line 
L929, which is very sensitive to the cytotoxic action of 
TNF. We found that TNF could indeed stimulate IL6 
gene expression; furthermore, WC’ could also demon- 
strate a close relationship between IL6 gene induction 
and cytotoxicity [7]. 
In the present study, we investigate TNF-induced IL6 
gene expression in the L929r2 cell line, a variant of 
L929s resistant o the cytotoxic action of TNF. Our 
present data demonstrate that IL6 gene expression is 
only weakly stimulated by TNF in this resistant cell line; 
however. when these cells are rendered sensitive by the 
combined action of TNT: and interferon (IFN)-y, the 
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IL6 gene expression could again be strongly induced 
and was regulated in parallel with the eel-killing effect 
of TNF. 
2. MATERIALS AND METHODS 
2. I , Cd/.s arrd I’PItjytf IS 
The murinc librosarcomo L929r2 cell line is a TNF-resistant sub- 
clone derived I’rom the original. wnsilivc L929 line [8]. Thiscloncdocs 
not produce TNF by itscll’. These adhcrcm cells were cultured in 
Dulbecco’s moditicd Eagle’s medium supplcmcnted wilh IO% he&t- 
inxtivutcd newborn calr serum, 100 U/ml penicillin. 0. I m&/ml slrcp- 
tomycin and 0.03% L-glutaminc. Recombinant murinc TNF from E. 
w/i was purified 10 99% homogeneity and stored in phosphatc-buf- 
I’crcd sdlinc tit -7U”C, It had a specilic activity of 1.9% IO” 1lJlm.g 
protein and contained <I 3 n&mg cndotoxin. Recombinant murinc 
IFN-y l?om E. co/i ws purilicul to 99% homogcncity und stored in 
phosphate-buffered sulinc tit -70°C; it had u specific activity of8 x I Oh 
Ulmg. Dcxilmethasol~e (DEX) was purchard from Sigma Chemical 
Co.. Poole. UK. LiCl was from Merck. Dnrmstodt. Germany. 
TOWI cyioplusmic RNA was isolalcd from L929rZ cells essentially 
as described [9] using an NP-40 lysis buffer. Several phcnollchloro~ 
form extractions were carried out to remove the prolcins from the 
lysllte; the cyloplusmic RNA was recovered by ethanol precipitation. 
Appropriate amounts of the isolated RNA, denatured with formal- 
dehyde. wcrc applied onto a nylon filler (Pall Biodync A; Pall BioSup 
porl, East Hills, NY. USA) in the presence or5x standard saline cilratc 
(SSC) and immobilized by heat treatment (I h at WC). Prehybridiza- 
tion (at lcdst I h at 42°C) and hybridization (overnight at 42°C) were 
ctirriLul OUL in u mixlure contuining 5x Dcnhardt’s solution. 5x SSC. 
50 mM sodium phosphate (pH 6.5). 0.1% sodium dodccyl sulfate 
(SDS). 250 @ml non.homologous DNA and 50% rormamidc. The 
final wushing steps were carriLd out with solutions containing 2x 
SSC:O. I% SDS (4x 5 min) and 0. Ix &SC/O, I % SDS. The hybridization 
probe was prcpar_‘d by digestion ol’the murine IL6 cDNA-containing 
plasmid pUCgMIL6 [IO] with EcuRl und gtll, and labeling of the 
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appropriate DNA l’ragment (655 bp) with a-32P nuclcotidcs usilre 
random primers (Bochringur. Mannkim. Cicrmunyj. 
The itmount or lL6 protein in hc medium of the L9?9 cells wils 
quntitotcd by their Browth-stimuliltillg cilpacity 011 7TDI ~11s 
[I 1,121. 
3. RESULTS 
3.1. IL6 gene e.~pressiott itt L929r2 cells ~rpott TNF IWCII- 
lm?ll~ 
In previous studies, we have reported on TNF-in- 
duced IL6 expression in the murine fibrosarcoma cell 
line L929s. which is highly sensitive to TNF cytotox- 
icity. Moreover, we could show a close correlation be- 
tween TNF-induced IL6 gene expression and cytotox- 
icity [7]. 
In the present study we investigated the effect of TNF 
treatment on IL6 gene expression in a TNF-resistant 
subclone of L929s, namely L929r2. Cells were grown to 
confluency as described and treated with TNF in the 
same way as before with L929s cells. The isolated RNA 
was spotted onto a nylon filter for dot-blot hybridiza- 
tion with a murine IL6 cDNA probe. 
As shown in Figs. 1 and 2 there is a slight increase of 
the IL6 mRNA levels after TN F treatment as compared 
to the non-induced cells, demonstrating that the IL6 
gene is only marginally inducible by TNF in this TNF- 
resistant cell variant. The values of the biological IL6 
assay (Fig. 2), measuring the amount of IL6 protein 
secreted in the medium, lead to the same conclusion and 
confirm our results published previously [131. 
3.2. iL.6 gene expwssion itt i.929PJ r’c#s II&Y cotrcliriotts 
of recovered serrsiriviry lo cyrotosicir~ 
Next, we investigated whether the synergism between 
TNF and IFN-y, which renders these cells sensitive to 
TNF [3,8,14], has any influence on TNF-mediated gene 
induction, 
In a first experiment we examined the effect of differ- 
ent IFN-y concentrations, After the cells bad been 
grown to confluency IO U/ml or 1000 U/ml IFN-y were 
applied to the cells, either alone or in combination with 
TNF (5,600 U/ml) for 21 h. After lysis and RNA extrac- 
tion the different RNA sa.mples were transfer-r-cd onto 
a nylon membrane in appropriate amounts. Hybridiza- 
tion with a radioactive IL6 cDNA probe was performed 
as described. The result is shown in Fig. 1. IFN-y by 
itself (in concentrations f either IO U/ml or 1,000 U/ml) 
causes a slight increase in the background level of IL6 
mRNA, similar to the effect seen with TNF alone, How- 
ever, the combined treatment of TNF together with 
IFN-y resulted in a very distinct stimulation of IL6 gene 
expression which, furthermore, was strongest at the 
highest concentration of IFN-y. 
In order to investigate the effect of increasing concen- 
trations of TNF, we set up the experiment shown in Fig. 
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2. From the data obtained by dot-blot hybridization. as 
well as from the biological activity of the IL6 secreted 
in the growth medium, it is clear that the levels of IL6 
mRNA were increased with increasing doses of TNF. 
However, an appreciable gene induction effect only oc- 
currrd under conditions of a combined treatment of 
TNF with IFN-y. Since the combined TNF/IFN-y 
treatment rendered the L929r2 cells sensitive again to 
TNF cytotoxicity these data clearly indicate that effi- 
cient IL6 gene induction and TNF-mediated cytotox- 
icity are closely linked also in L929r2 cells. This close 
correlation confirms the results obtained in our previ- 
ous studies with the sensitive cell type of this murinc 
tibrosarcoma cell lineage. 
LiCl is known to be a strong enhancer of TNF cyto- 
toxicity [15]. while DEX reduces the sensitivity of the 
cells for TNF-induced cytotoxicity [ 161. We next investi- 
gated the effect of these agents on IL6 induction in the 
L929r2 cell line. Confluent monolayers of L929r2 cells 
were treated with TNF/LiCl or TNF/DEX, with or 
without addition of IFN-y. After extraction of cytoplas- 
mic RNA, the samples were fixed on a nylon filter and 
hybridized with a radioactive IL6 cDNA probe. The 
results are shown in Fig, 3. Again, TNF treatment re- 
sulted in an elevated background level of IL6 mRNA, 
which could be further increased by co=treatmcnt with 
LICI; similar results were obtained previously at the 
protein level [13]. On the other hand, DEX completely 
reduced the elevated IL6 mRNA level. When IFN-)I 
was added the TNF-produced IL6 mRNA signal was 
strongly incrc’;tic d and could be further enhanced by the 
potentiating effect of LiCl. Also in this case, DEX, an 
inhibitor ofcytotoxicity, was able to completely abolish 
the induced IL6 mRNA signal. 
In brief, the regulation of the ILG gene under condi- 
tions of enhanced or reduced cytotoxicity, as observed 
in the L929s cells, is also true for the L929r2 variant 
after it had been rendered sensitive to TNF by co-treat- 
ment with IFN-y. However, when the cells were kept 
fully resistant o TNF only marginal amounts of IL6 
induction could be visualized following induction with 
TNF. 
4. DISCUSSION 
IL6 is a multifunctional cytokine which is inducible 
by various low-molecular weight compounds or by cy- 
tokines, such as IL1 or TNF 1171. The induction of IL6 
is not a general phenomenon but is dependent on the 
cell type used. We have already found that, as far as the 
murine l-929 ce!! !ine is concerned (which is very sensi- 
tive to the cell killing effect of TNF) IL6 gene induction 
by TNF is closely related to TNF-mediated cytotox- 
icity. From this we concluded that the signaling path- 
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Fig. 1. Induction of IL< mRNA with TNF and dilkrcnt eoncentra- 
tions of IFN-y. Total cytoplasmic RNA was isolated from non-in- 
duced L929rZ cells (lane I), or L929r2 cells trcatcd for 21 h with TNF 
(5.600 U/ml; lane 2). or IFN-y (IO U/ml; lane 3). IFN-)I (1.000 U/ml: 
lane 5), or with the combination of TNF (5,600 U/ml) and IFN-y (IO 
U/ml; lane 4), or TNF (5,600 U/ml) and IFN-y (I .OOO U/ml: lunc 6). 
30 ~6 ol’ the isolated cytoplasnric RNA from each cxperimcnt was 
serially diluted (3Jold dilution steps) and immobilized on Pall Biodync 
A nylon membranes: hcncc. the consecutive lanes correspond to 20, 
6.7. 2.2 and 0.7 pg. rcspcctively. TIK filter wus hybridized with ir 
radioactive murinc IL6 cDNA probe and. al’tor scvcrul washing steps, 
cxposcd to un X-ray lilm, 
way giving rise to IL6 gene induction in response to 
TNF, coincides, at least partially, with the reaction 
mechanisms taking place in the cytoplasm and finally 
leads to cell death [7]. 
Therefore. it was of particular interest o investigate 
how IL6 gene expression is affected in a related, TNF- 
resistant cell line. Because the L929r2 cell variant is 
derived from the L929 TNF-sensitive cell line studied 
previously we have chosen this resistant cell type for the 
present studies. When these L929r2 cells were treated 
with increasing concentrations of TNF, the IL6 cxpres- 
sion levels were enhanced as compared to the back- 
ground level in non-induced cells, showing that the ac- 
quired resistance mechanisms to TNF lysis had not 
completely abolished the signaling pathway for IL6 
gene induction. However, when L929r2 ceils were sub- 
jected to the combined treatment of TNF and IFN-y. 
a treatment by which the resistant cells become s nsitive 
again to the lytic action of TNF, the IL6 gene became 
strongly induced. Furthermore, and analogous to the 
effects observed with the original L929-sensitive cells, 
this induction of IL6 expression could still be further 
enhanced by the addition of LiCI, or, on the other hand, 
reduced by DEX treatment o a level below the one 
present in these els treated with TNF but in the absence 
of IFN-y. 
The present data extend and further support our prc- 
vious findings concerning the interconnection between 
IL6 gene induction and cytotoxicity in response to 
TNF. They suggest hat the ongoing cytotoxicity reac- 
Fig, 2. Induction of IL6 mRNA with increasing concentrations of 
TNF. L929r2 cells were grown to eonfluency and treated for 24 h with 
1.000 U/ml (lane 3), S.600 U/ml (lane 5) or 12.500 U/ml (lane 7) of 
TNF. either done or in combination with I.000 U/ml IFN-y (lanes 
4. 6 and 8. ruspcctivcly). 30 ~16 of total cytoplasmic RNA from m-t. 
trcatcd cells (lane I ). cells trcatcd with I.000 U/ml IFN-y (lane 2). or 
rrom cells lrcdlcd as indicated above. was isolated and used for dot- 
blot hybridiwtion as described above The values undcrncath rcpre- 
sent the irmount of IL6 protein in the medium, us mcdsured in an IL6 
bioassay. 
tions are largely identical to those leading to abundant 
IL6 expression. 
The signaling pathway(s) going to the nucleus for 
gene induction is (are), as far as the L929 cell system is 
concerned, at least in part determined by cytoplasmic 
events. Nevertheless, the signaling system for I LB gene 
expression is not completely blocked or overruled in the 
resistant state. and thus may represent a basal state of 
TNF-inducible (and regulatable) gene expression. Only 
when cytoplasmic reactions amenable to cell killing arc 
operative does the IL6 gene expression become fully 
induced. In agreement with this conclusion is the obser- 
vation that agents which increase the toxic effect of 
TNF in 1929 cells, uch as LiCI, in parallel enhance 1 L6 
expression both in L929 and L929r2 cells, while com- 
pounds that restrict he killing effect of TNF also dimin- 
ish IL6 expression level. It appears as if there exists. 
besides the pathway leading to basal TNF-mediated 
expression, another additional signaling system for su- 
perimposed, abundant gene expression. proceeding in 
parallel with and determined by the cytoplasmic reac- 
tions for cellular toxicity. This scheme of a dual signal- 
ing system for TNF-induced IL6 gene expression is now 
being further explored. 
As already mentioned previously, NF-xl3 is an im- 
portant factor for TNF-mediated gene induction. Al- 
though different studies have shown rapid activation of 
NF-KB after TNF treatment [18.19], and although this 
is also true for L929 (N. Patestos, G. Haegeman. V. 
Vandevoorde and W. Fiers. in preparation), it is not 
known whether NF-KB activation also plays a role in 
the onset of cellular toxicity, which is a much later 
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Fig. 3. Regulation of the IL6 mRNA level in the TNF-resistant and 
TNF-sensitive state of the L929r2 cells, L929r2 cells were grown to 
conflucncy and treated for 5 h with 1.000 U/ml IFN-y (lane 2). 5.600 
U/ml TNF (lane 3). 5.600 U/ml TNF and IO mM LiCl (lime 4). 5.600 
U/ml TNF und 0. I mM DEX (lunc 5). a combination 01’ 5.600 U/ml 
TNF and 1.000 U/ml IFN-y (lane 6), ;I combination of 5.600 U/ml 
TNF, 1.000 U/ml IFN.1 and IO mM LiCl (Innc 7). or u combinution 
of 5,600 U/ml TNF. 1.000 U/ml IFN-y and 0. I IIIM DEX (lane 8). 
LiCl and IFN-y were applied to the cells at the sume time as TNF: 
DEX was added 2 h bcforc. Total cytoplusmic RNA w;is isolutcd and 
3Oyg wus taken for a dot-blot hybridization ;Is described in the legend 
IO Fig. I. Lilne I conl;lins the RNA of non.induced cells. 
event. Certainly there is good evidence that NF-KB is 
important for activation of the IL6 gene transcription 
[20-221, but i remains un open question whether the 
close relationship between IL6 expression Lund TNF- 
induced cytotoxicity can be explained by ihis single fac- 
tor. This aspect is now under further investigation. 
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